---
category: listing
circular_id: 530c30b64df059f0
date: '2025-11-26'
description: 15,45,000 equity shares of Novelix Pharmaceuticals Limited (Scrip Code
  536565) issued at Rs. 20/- on preferential basis pursuant to warrant conversion,
  listed and permitted to trade from November 27, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2A893E66-D35D-4318-83A9-72B9CC582A97}&noticeno=20251126-52&dt=11/26/2025&icount=52&totcount=68&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing notice for preferential allotment of shares pursuant
  to warrant conversion. Limited market impact as it affects a single company's expanded
  share capital with lock-in restrictions.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251126-52&attachedId=
processing:
  attempts: 1
  content_hash: c3228364cd71360c
  processed_at: '2025-11-26T15:35:11.841730'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-26T12:42:23+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2A893E66-D35D-4318-83A9-72B9CC582A97}&noticeno=20251126-52&dt=11/26/2025&icount=52&totcount=68&flag=0
severity: low
source: bse
stocks:
- NOVELIX
tags:
- listing
- equity-shares
- preferential-allotment
- warrant-conversion
- lock-in
- novelix-pharmaceuticals
title: Listing of New Securities of Novelix Pharmaceuticals Limited
---

## Summary

NovelixPharmaceuticals Limited (Scrip Code: 536565) has listed 15,45,000 new equity shares of Rs. 10/- each issued at a premium of Rs. 10/- (total issue price Rs. 20/-) on the BSE. These shares were allotted on August 14, 2025, to Promoters and Non-Promoters on a preferential basis pursuant to conversion of warrants. The shares will be available for trading from November 27, 2025, and rank pari-passu with existing equity shares.

## Key Points

- Total new shares listed: 15,45,000 equity shares of Rs. 10/- each
- Issue price: Rs. 20/- per share (including premium of Rs. 10/-)
- Basis of issue: Preferential allotment pursuant to warrant conversion
- Allottees: Promoter and Non-Promoter categories
- Distinctive Numbers: 12935001 to 14480000
- ISIN: INE314I01036
- Trading commencement: November 27, 2025
- Shares rank pari-passu with existing equity shares

## Regulatory Changes

No regulatory changes announced in this circular.

## Compliance Requirements

- Trading members are informed to note the listing of these new securities
- Lock-in restrictions apply to the allotted shares as specified
- The securities will be available for trading subject to lock-in provisions

## Important Dates

- **Allotment Date**: August 14, 2025
- **Trading Commencement**: November 27, 2025
- **Lock-in Expiry (6,45,000 shares)**: June 30, 2026
- **Lock-in Expiry (9,00,000 shares)**: June 30, 2027

## Lock-in Details

- 9,00,000 shares (Dist. Nos. 12935001 to 13835000) locked-in until June 30, 2027
- 6,45,000 shares (Dist. Nos. 13835001 to 14480000) locked-in until June 30, 2026

## Impact Assessment

**Market Impact**: Low. This is a routine listing of shares pursuant to warrant conversion on preferential basis. The quantum of shares (15.45 lakh) represents capital expansion for the company.

**Liquidity Impact**: Limited immediate impact on liquidity as all 15,45,000 shares are subject to lock-in restrictions ranging from 6 months to 1.5 years from the notice date.

**Investor Impact**: Existing shareholders should note the dilution in equity share capital. New shares rank equally with existing shares in all respects including dividend rights.